STOCK TITAN

Definitive Healthcare Corp. - DH STOCK NEWS

Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.

Company Overview

Definitive Healthcare Corp (DH) is a renowned provider of healthcare commercial intelligence and an expert in leveraging a robust SaaS platform to transform complex healthcare data into actionable insights. As a subscription-based service, it aggregates and refines vast amounts of information from a diverse array of healthcare providers including hospitals, physicians, ambulatory surgery centers, imaging centers, long-term care facilities, and more. Using advanced data science and analytics, the company delivers a comprehensive view of the healthcare ecosystem in the United States, empowering clients to develop data-driven strategies, segment markets accurately, and optimize commercial operations with confidence.

Business Model and Revenue Generation

The company’s business model is anchored in the provision of a versatile, subscription-driven platform that delivers uninterrupted access to high-quality, curated data. Rather than relying on periodic sales cycles or one-off engagements, Definitive Healthcare focuses on maintaining continuous customer relationships through its SaaS-based service offerings. Clients—all of whom are stakeholders in healthcare, from provider networks and pharmaceutical companies to medtech organizations and insurance companies—benefit from regular updates, quality-assured data, and seamless integration into their operational workflows. Revenue is generated mainly through recurring subscriptions and tailored support services, which reflects the company’s commitment to delivering ongoing value to its customers.

Key Solutions and Product Offerings

Definitive Healthcare has developed an extensive array of solutions designed to address the multi-dimensional needs of its users. Its product suite emphasizes:

  • Comprehensive Data Aggregation: The platform curates data on thousands of healthcare facilities and professionals, facilitating market segmentation, competitive analysis, and strategic planning.
  • Advanced Analytics and Data Science: Through the use of deep analytics, clients are provided with granular insights that help identify critical market trends and refined customer segments, essential for tailored go-to-market strategies.
  • Mobile and On-Demand Intelligence: The DH View Suite mobile app ensures that crucial intelligence is accessible anywhere at any time, allowing sales and marketing teams to be prepared in real time.
  • Predictive and Scenario Analysis: Tools such as Market Forecast enable organizations to visualize market trends and demand projections, equipping decision-makers with a forward-looking view of service line opportunities while remaining grounded in historical data and proven analytic models.
  • Integrated Engagement Solutions: Through products like Monocl Conferences and Population Intelligence, the company facilitates seamless connection and collaboration among pharmaceutical companies, KOLs, and life science organizations, streamlining conference planning and audience targeting processes.

Data and Analytics Excellence

At the core of Definitive Healthcare’s offering is its commitment to accurate, comprehensive, and continuously updated data. The platform employs advanced methodologies to ensure that the information provided is not only extensive but also contextually enriched. Clients benefit from detailed profiles that extend beyond mere lists of providers to include insights into clinical performance, financial health, quality metrics, and the adoption of installed technologies. This meticulous approach to data quality ensures that healthcare professionals and corporate teams have both the breadth and depth of information required for thorough market research and intelligent strategic planning.

Market Position and Competitive Advantage

Within the crowded field of healthcare data providers, Definitive Healthcare distinguishes itself through its scale, the granularity of its data, and its ability to integrate diverse analytics into a holistic intelligence platform. The company serves multiple market segments, effectively bridging the gap between data generation and actionable intelligence. This approach not only supports traditional market research but also allows clinical and commercial teams to uncover new market opportunities, tailor their engagement strategies, and refine customer segmentation with exceptional precision. The combination of customizable tools and real-time access to data is a significant differentiator in an industry where time-sensitive insights can be the key to unlocking commercial success.

Client Impact and Applications

Definitive Healthcare’s impact is realized across various facets of the healthcare industry. For sales and marketing teams, the mobile-first solutions provide a tactical edge enabling pre-meeting preparation and post-engagement follow-up. Strategic planners and market analysts utilize advanced predictive tools like Market Forecast to identify emerging trends and allocate resources efficiently. Moreover, the integration of comprehensive data with intuitive platforms empowers organizations to recalibrate their go-to-market strategies, optimize operational performance, and achieve cost efficiencies without sacrificing the quality of engagement. The platform’s design is inherently flexible, catering to the unique requirements of diverse client types—from academic medical centers to global pharmaceutical corporations—thus ensuring that every customer derives maximum value from their investment in data-driven insights.

Expertise, Experience, and Industry Authority

Definitive Healthcare embodies the principles of Expertise, Experience, Authoritativeness, and Trustworthiness (E-E-A-T) in every facet of its operations. The company employs industry veterans and data scientists who specialize in healthcare analytics, ensuring that the intelligence provided is rooted in practical experience and rigorous analysis. Its commitment to accuracy and depth is reflected in every aspect of its data curation process, with an unwavering focus on eliminating inaccuracies and delivering value through meticulous data management. This disciplined approach to quality control not only elevates the standard of commercial intelligence in the healthcare arena but also instills trust among its clients, who rely on the platform for critical decision-making and strategic direction. Additionally, the company’s open engagement with its marketplace through educational webinars, conference presentations, and thought leadership articles further underscores its standing as a bidder of expert insight in the dynamic healthcare landscape.

Operational Excellence and Integration

Operationally, the company is designed for adaptability and precision. Its cloud-based infrastructure allows for seamless updates and integration with internal systems, ensuring that organizations do not encounter disruptions in their workflows. Whether accessed via desktop or mobile devices, the platform’s intuitive interface facilitates a smooth user experience. This operational excellence has made it a critical tool for organizations that need to remain agile in response to rapid changes in market conditions and technological advances. With an emphasis on continuous improvement and innovation, Definitive Healthcare frequently enhances its product offerings, incorporating refined analytics, enhanced user interface features, and expanded data points that collectively offer a potent mix of depth, detail, and usability.

Industry Insights and Continuous Learning

The company’s overarching mission is to transform fragmented data sources into a cohesive intelligence framework that supports the dynamic needs of modern healthcare professionals. Its expansive database serves as both a repository of historical trends and a catalyst for future innovation, enabling clients to stay ahead by basing strategies on robust, integrative intelligence. By powering strategic conversations around healthcare trends, patient demographics, and market dynamics, Definitive Healthcare is not only addressing current challenges but also enabling its clients to anticipate future developments with a well-informed perspective. The platform’s capacity to integrate real-time data with predictive analytics creates a compelling value proposition for stakeholders looking to fortify their competitive positioning in a constantly evolving healthcare landscape.

Conclusion

In summary, Definitive Healthcare Corp stands out as a key provider of healthcare commercial intelligence, renowned for its comprehensive data platform, advanced analytical tools, and commitment to delivering precise, actionable insights. Through its diverse suite of products and an unwavering focus on operational excellence and data quality, the company facilitates informed strategic decision-making and robust market intelligence across the healthcare industry. Whether for identifying new market opportunities, optimizing sales strategies, or refining operational approaches, the platform’s capacity to integrate data, analytics, and real-world expertise underscores its essential role in navigating the complexities of today’s healthcare market.

Rhea-AI Summary

Definitive Healthcare (Nasdaq: DH) has launched Monocl ExpertInsight 2.0 and its mobile app Monocl ExpertGO, revolutionizing expert identification in healthcare. This platform grants medical affairs teams access to nearly 13 million expert profiles globally, enhancing productivity and streamlining workflows. Key features include live filters, advanced search options, and KOL mapping. Brazilian healthcare data has also been added to the platform. Existing customers can access these tools at no extra cost, aimed at accelerating drug and device market readiness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.42%
Tags
none
-
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) will present at the Stifel 2022 Cross Sector Insight Conference. The session is scheduled for June 7, 2022, at 1:15 p.m. Eastern Time, featuring CEO Jason Krantz, CFO Rick Booth, and President Robert Musslewhite. Interested parties can access a live webcast on Definitive Healthcare's investor relations website, with a replay available for a limited time. Definitive Healthcare specializes in healthcare commercial intelligence, using data and analytics to help clients succeed in the healthcare market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.57%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
conferences
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) announced that CEO Jason Krantz and CFO Rick Booth will present at the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference. The presentation is scheduled for May 23, 2022, at 9:20 a.m. Eastern Time. A live webcast will be accessible through their investor relations website, with a replay available for a limited time. Definitive Healthcare specializes in healthcare commercial intelligence, providing clients insights to drive success in the healthcare market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
conferences
-
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) reported a 36% year-over-year increase in first-quarter revenue, reaching $50.1 million compared to $36.9 million in Q1 2021. Despite a net loss of ($13.1) million, which is 26% of revenue, the company showed strong operational cash flow at $13.6 million, or 27% of revenue. Adjusted net income rose to $7.7 million, highlighting profitability amidst growth. Looking ahead, the company forecasts Q2 2022 revenue between $53.0 - $54.0 million, indicating continued momentum.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.45%
Tags
-
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) announced the appointment of Robert Musslewhite as the new CEO, effective August 1, 2022. Founder Jason Krantz will transition to Executive Chairman but will remain involved in the company's strategic direction. Musslewhite, previously President, has a strong SaaS and healthcare background, including experience as CEO at OptumInsight and The Advisory Board Company. He aims to leverage his expertise to further advance the company's growth. Definitive Healthcare emphasizes its commitment to healthcare commercial intelligence with nearly 3,000 customers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.45%
Tags
none
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) announced that it will release its first quarter financial results for the period ending March 31, 2022, on May 5, 2022, after market close. A conference call and webcast will be held at 4:30 PM ET to discuss these results. Interested parties can access the audio webcast on Definitive Healthcare's Investor Relations website. A replay of the call will be available until May 19, 2022, using the provided dial-in numbers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.84%
Tags
-
Rhea-AI Summary

Definitive Healthcare (Nasdaq: DH) has launched the Passport Analytics Suite, designed to enhance the efficiency of life sciences organizations in product development and commercialization. Powered by technologies from the recently acquired Analytical Wizards, the suite includes Passport Promotional Analytics and Passport Planning & Performance. These tools enable clients to optimize brand performance, marketing strategies, and product planning by integrating diverse data sources. This innovation positions Definitive Healthcare as a leader in offering comprehensive, data-agnostic analytics solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9%
Tags
none
-
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) has announced its participation in two key conferences in March 2022. The company will present at the Raymond James 43rd Annual Institutional Investors Conference on March 7 at 1:05 PM ET, featuring CEO Jason Krantz and CFO Rick Booth. Additionally, they will present at the Deutsche Bank 30th Annual Media, Internet & Telecom Conference on March 14 at 10:20 AM ET, with President Robert Musslewhite and CFO Booth. Both events will be webcast live, with replays available later.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.09%
Tags
conferences
Rhea-AI Summary

Definitive Healthcare reported a 38% increase in Q4 2021 revenue to $46.3 million, while full-year revenue grew 40% to $166.2 million. Despite a GAAP net loss of $(14.8) million in Q4, adjusted net income rose to $6.6 million. Adjusted EBITDA in Q4 was $13.1 million, or 28% of revenue. For 2022, the company projects revenue between $218 million and $222 million. Key highlights include significant new contracts with major healthcare companies and the launch of a new product, Latitude Reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.4%
Tags

FAQ

What is the current stock price of Definitive Healthcare (DH)?

The current stock price of Definitive Healthcare (DH) is $2.53 as of April 18, 2025.

What is the market cap of Definitive Healthcare (DH)?

The market cap of Definitive Healthcare (DH) is approximately 292.4M.

What is Definitive Healthcare Corp?

Definitive Healthcare Corp (DH) provides a SaaS-based platform delivering comprehensive, high-quality data and analytics on the healthcare ecosystem to support informed decision-making.

How does Definitive Healthcare generate revenue?

The company primarily generates revenue through subscription fees for access to its commercial intelligence platform, which includes continuous support and periodic updates.

What types of healthcare providers are included in its data?

The platform aggregates data on various healthcare providers, including hospitals, physicians, ambulatory surgery centers, imaging centers, long-term care facilities, and more.

How does the DH platform aid in strategic planning?

It delivers detailed analytics, predictive modeling, and market segmentation tools that enable clients to identify new market opportunities and refine their go-to-market strategies.

What are some of the key product offerings of Definitive Healthcare?

Key offerings include the core commercial intelligence platform, mobile solutions like DH View Suite, predictive tools such as Market Forecast, and integrated engagement solutions through products like Monocl Conferences.

Who are the typical clients of Definitive Healthcare?

The platform serves a broad range of clients including healthcare providers, pharmaceutical companies, medtech organizations, and other stakeholders requiring detailed market and operational insights.

How is data quality maintained on the platform?

Definitive Healthcare uses advanced analytics and rigorous data curation methodologies to ensure accuracy, comprehensiveness, and contextual relevance across its extensive database.

How does Definitive Healthcare differentiate itself from competitors?

Through its expansive data coverage, advanced analytics, mobile accessibility, and integrated suite of tools, the company offers a robust, dynamic intelligence platform that stands apart in the healthcare sector.
Definitive Healthcare Corp.

Nasdaq:DH

DH Rankings

DH Stock Data

292.44M
40.31M
7.14%
94.68%
2.46%
Health Information Services
Services-prepackaged Software
Link
United States
FRAMINGHAM